Nu-Med Plus, Inc. Files for Patent on Portable Rapid Distribution Inhaled Nitric Oxide Generator

Nu-Med Plus, Inc. (OTCBB: NUMD) applied for a patent for its new portable rapid distribution Nitric Oxide generating technology.
According to the company’s press release:

Nitric oxide is a medically essential gas that is presently used in Neonate Hypoxia therapy. Contemporary research is being done for additional applications involving the therapeutic need for vasodilation and increased delivery of oxygen to diseased and injured tissues. Nu-Med Plus has developed a unique concept for the generation of Nitric Oxide that has the capability to rapidly deliver the gas when serious and instantaneous use is needed. A patent has been applied for protecting this innovative advancement.

Mr. Jeff Robins, President/CEO of Nu-Med Plus commented:

Nu-Med’s goal is to expand its intellectual property portfolio by developing exceptional products like our portable rapid distribution technology which should enable us to add value to the company and increases our competitive advantage.

Click here to view the press release.